These FAQs are based on the best available information we have at this time. COVID-19 vaccination supply and eligibility vary across the country. We will do our best to provide our beneficiaries the latest information in a timely manner. This page will be updated as new information becomes available; please check back often. This page was most recently updated on 3/31/2021.
The Funds is committed to the health and safety of Funds’ beneficiaries. Following is important information related to common questions regarding the COVID-19 Vaccine
We understand there are concerns about the safety of the COVID-19 vaccines. The U.S. Food and Drug Administration (FDA) undertakes a rigorous evaluation of the scientific information through all phases of the clinical trials of a vaccine. This rigorous evaluation process continues after a vaccine has been approved by FDA or authorized for emergency use. The FDA has approved three (3) vaccines for emergency use that it finds are safe and effective and may approve additional vaccines in the future. We are confident in the FDA’s approval process.
On rare occasions, some people have experienced a reaction to the injection. The healthcare provider who administers the vaccine will monitor you for a short time following the injection and can assist you should a reaction occur. If you have concerns due to reactions you have had to a vaccine or injectable therapy for another disease, have been recently immunized for other diseases, or have recently received antibody therapy for a COVID-19 illness, ask your doctor if you should get a COVID-19 vaccine. Your doctor will help you decide if it is safe for you to get vaccinated.
As a reminder, you cannot develop COVID-19 from these vaccines.
Federal guidelines prioritize the vaccination of certain vulnerable populations before vaccines are made available to the general public. While supplies are limited, many states are relying on mass vaccination clinics in their states.
Most states are open for vaccine eligibility to all adults aged 16 and up and have pre-registration systems available. Additionally, patients aged 12-15 are now eligible for the Pfizer-BioNTech vaccine. Please find eligibility guidelines and contact information for your state here.
Appointments will be required to receive a vaccination at CVS, other retail pharmacies as well as mass vaccination sites. Customers will be able to schedule their vaccinations—both the initial shot and the required second dose—at CVS.com or through the CVS app. Some sites are offering a phone number to call if you don’t have access to the internet. If you are able to, ask for help from a friend, family member, or neighbor if you need help scheduling your vaccine.
All the major national chains and several regional chains are helping the government administer as many vaccinations as possible. Pharmacies participating in the administration of the vaccine once it is broadly available can be found here.
The federal government will cover the cost of the vaccine. The Funds will cover the cost for the health care provider to administer the vaccine. There will be no cost to beneficiaries. If your healthcare provider asks for your health insurance information, please show them your Funds health insurance card.
The federal and state governments will determine which vaccines are available for your state to receive. Pharmacies will adhere to Centers for Disease Control (CDC) and FDA guidance on administration of the vaccines.
Two vaccines (Pfizer and Moderna) that have been authorized to date require two injections for the best protection, while one vaccine (Johnson & Johnson) is effective after only one dose. For the two dose vaccines, one injection may not give full immunity to the virus; therefore, it is important that you receive both injections if you receive either Pfizer or Moderna.
Remember that the vaccines take some time to build up your immunity to COVID, in most cases two weeks after you have received your second dose of a two-dose vaccine regimen your body will have some protection against COVID.